Cadila Healthcare

BSE : 532321 | NSE : CADILAHC

Industry : Pharmaceuticals | ISIN : INE010B01027 | FreeFloat : 30.00% | FnO : Yes | LotSize : 5000


Intellectual Capital (IC)16,838.90
Net Worth (NW)13,633.90
Intrinsic Worth (IW)30,472.80
Market Cap (MC)40,442.95
Economic Value Added-0.72
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)55.26%
IC Gross Margin (EBITDA/IC)16.33%
IC Net Margin (NPT/IC)7.60%
Knowledge Turnover (Sales/IC)0.91
Market to Intrinsic Value (MC/IW)1.33

As OfIntrinsic ValueMarket Price
30 Sep 2020Rs. 297.66Rs. 395.05
22 Jan 2021 - Rs. 460.50
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 483.67SellStrong Sell
KB > 50% : Yes50 DMA : Rs. 464.70
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-17
C
3259.60
3300.70
882.30
735.00
721.50
543.30
576.40
Mar-18
C
3250.20
3278.90
899.10
755.10
739.70
590.80
567.50
Jun-18
C
2893.70
2995.00
746.30
604.50
569.50
449.20
349.60
Sep-18
C
2961.20
2991.60
718.20
570.70
535.00
417.50
265.70
Dec-18
C
3577.90
3608.90
870.90
717.20
671.70
510.70
605.80
Mar-19
C
3732.80
3771.20
838.80
683.20
605.90
479.20
509.60
Jun-19
C
3496.30
3518.90
654.60
483.00
393.90
303.60
360.30
Sep-19
C
3366.60
3393.50
384.40
212.10
122.40
107.20
-7.00
Dec-19
C
3638.10
3658.20
711.70
537.60
457.10
373.90
356.70
Mar-20
C
3752.10
3796.40
783.00
604.50
522.00
391.90
193.90
Jun-20
C
3639.90
3662.40
837.90
661.10
593.40
454.00
463.80
Sep-20
C
3820.00
3847.50
758.90
579.90
534.20
473.40
554.70
* C - Consolidated, S - Standalone